ResearcherUniversity Medical Center UtrechtActive in the last 2 years

Patricia A. Olofsen

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-6100-9290; OpenAlex author ID A5007789923.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 6

Papers, trials and grants by year

2025: 2 papers

Papers 2

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cells14090632 ↗
Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms262311385 ↗

Closest collaborators

The 6 strongest of 6 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Lois A. Daamen · 2 shared papers, 2025
- Paper Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms262311385 ↗
- Paper The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells14090632 ↗
Martijn Intven · 2 shared papers, 2025
- Paper Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms262311385 ↗
- Paper The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells14090632 ↗
Léon Raymakers · 2 shared papers, 2025
- Paper Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms262311385 ↗
- Paper The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells14090632 ↗
Reinier A P Raymakers · 1 shared paper, 2025
- Paper Quantification of Signal Transduction Pathway Activity in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms262311385 ↗
Izaak Quintus Molenaar · 1 shared paper, 2025
- Paper The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells14090632 ↗
Hjalmar C. van Santvoort · 1 shared paper, 2025
- Paper The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cells14090632 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.